Christopher K. Scott - 04 Dec 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role: COO, CFO & Secretary
Signature: /s/ Christopher K. Scott
Issuer symbol: IRMD
Transactions as of: 04 Dec 2021
Net transactions value: -$51,604
Form type: 4
Filing time: 08 Dec 2021, 15:18:28 UTC
Previous filing: 24 Nov 2021
Next filing: 09 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRMD	Common Stock	Options Exercise		+2,952	+10%		31,547	04 Dec 2021	Direct	F1
transaction	IRMD	Common Stock	Tax liability	$51,604	-1,162	-3.7%	$44.41	30,385	04 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRMD	Restricted Stock Units	Options Exercise	$0	-2,952	-100%	$0.000000^*	0	04 Dec 2021	Common Stock	2,952		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.